Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5: Affected lots exceed the acceptable intake limit for N-nitroso-folic acid

Brand(s)

Last updated

2024-11-06

View history

Summary

Product

Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5

Issue

Health products - Product safety

What to do

Consult your health care professional if you have any health concerns.

Distribution

National

Alberta

British Columbia

Manitoba

New Brunswick

Newfoundland and Labrador

Ontario

Quebec

Saskatchewan

Brand	Product Name	Market Authorization	Dosage Form	Strength	Lot Numbers
JAMP Pharma	Pregnancy Multivitamin	DIN 02535718	Tablet	Blue tablets only: Folic acid 1.1 mg / Vitamin B12 12 mcg / Vitamin D3 600 IU / Calcium 300 mg	LKE08 Additional Lots: LKE05, LKE07, LKE09
JAMP Pharma	Pregnancy Multivitamin Folic 5	DIN 02537478	Tablet	Dark Blue tablets only: Folic acid 5 mg / Vitamin B12 12 mcg / Vitamin D3 600 IU / Calcium 300 mg	LKE10, LKE11, LKE14

Affected lots exceed the acceptable intake limit for N-nitroso-folic acid

Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.

Background

Depth of recall: Retailers

Details

Original published date: 2024-10-16

Alert / recall type

Health product recall

Receive notifications for new and updated recalls and alerts by category.